Famotidine and long QT syndrome.
Numerous drugs have been implicated in causing a prolonged QT interval and Torsades de pointes. However, the association of famotidine and acquired long QT syndrome has rarely been reported. We report 2 cases of famotidine-associated acquired long QT syndrome.
Lee
Ken W
KW
Division of Cardiology, Cardiac Electrophysiology Section, University of California at San Francisco, 500 Parnassus Avenue, MU East 4, Box 1354, San Francisco, CA 94143, USA. klee@medicine.ucsf.edu
Kayser
Steven R
SR
Hongo
Richard H
RH
Tseng
Zian H
ZH
Scheinman
Melvin M
MM
D000368:Aged; D000369:Aged, 80 and over; D003937:Diagnosis, Differential; D004562:Electrocardiography; D015738:Famotidine / Q000009:adverse effects*; D006333:Heart Failure; D006635:Histamine H2 Antagonists / Q000009:adverse effects*; D006801:Humans; D008133:Long QT Syndrome / Q000139:chemically induced* / Q000175:diagnosis* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction
D006635:Histamine H2 Antagonists; D015738:Famotidine